Deming, Yuetiva
,
Li, Zeran
Kapoor, Manav
Harari, Oscar
Del-Aguila, Jorge L.
Black, Kathleen
Carrell, David
Cai, Yefei
Fernandez, Maria Victoria
Budde, John
Ma, Shengmei
Saef, Benjamin
Howells, Bill
Huang, Kuan-lin
Bertelsen, Sarah
Fagan, Anne M.
Holtzman, David M.
Morris, John C.
Kim, Sungeun
Saykin, Andrew J.
De Jager, Philip L.
Albert, Marilyn
Moghekar, Abhay
O’Brien, Richard
Riemenschneider, Matthias
Petersen, Ronald C.
Blennow, Kaj
Zetterberg, Henrik
Minthon, Lennart
Van Deerlin, Vivianna M.
Lee, Virginia Man-Yee
Shaw, Leslie M.
Trojanowski, John Q.
Schellenberg, Gerard
Haines, Jonathan L.
Mayeux, Richard
Pericak-Vance, Margaret A.
Farrer, Lindsay A.
Peskind, Elaine R.
Li, Ge
Di Narzo, Antonio F.
Kauwe, John S. K.
Goate, Alison M.
Cruchaga, Carlos http://orcid.org/0000-0002-0276-2899
,
Funding for this research was provided by:
National Institute on Aging (R01AG044546, RF1AG053303)
National Institute on Aging (P01AG003991)
Article History
Received: 1 December 2016
Revised: 8 February 2017
Accepted: 14 February 2017
First Online: 28 February 2017
Compliance with ethical standards
:
: KB and HZ are co-founders of Brain Biomarker Solutions in Gothenburg AB, a GU Venture-based platform company at the University of Gothenburg, Sweden. A.M.G. serves on the SAB for Denali Therapeutics and is the inventor on a patent for MAPT mutations.
: This work was supported by grants from the National Institutes of Health (R01AG044546, P01AG003991, RF1AG053303, R01AG035083, and R01NS085419), and the Alzheimer’s Association (NIRG-11-200110). This research was conducted while C.C. was a recipient of a New Investigator Award in Alzheimer’s disease from the American Federation for Aging Research. C.C. is a recipient of a BrightFocus Foundation Alzheimer’s Disease Research Grant (A2013359S). The recruitment and clinical characterization of research participants at Washington University were supported by NIH P50 AG05681, P01 AG03991, and P01 AG026276. ADGC is supported by grants from the NIH (#U01AG032984) and GERAD from the Wellcome Trust (GR082604MA) and the Medical Research Council (G0300429); additional support was provided by NCRAD (U24 AG21886), NACC (U01 AG016976), NIAGADS (U24-AG041689) and UPENN (P30 AG010124). Support for A.S. was provided by U01 AG024904, R01 AG19771, and P30 AG10133. P.D.J. received support from R01 AG048015. UW ADRC received funding from AG05136. S.K. received support from NIA R03AG050856, Alzheimer’s Association, Michael J. Fox Foundation, and ARUK Biomarkers Across Neurodegenerative Diseases (BAND). M.R. received support from the German Federal Ministry of Education and Research (BMBF) National Genome Research Network (NGFN) Grant No. 01GS08125 and through the Helmholtz Alliance for Mental Health in an Aging Society (HELMA) Grant No. Ha-15. This work was supported by access to equipment made possible by the Hope Center for Neurological Disorders and the Departments of Neurology and Psychiatry at Washington University School of Medicine.